Argentina

BMI View: Corporación Farmacéutica Recalcine (CFR)'s foreign expansion strategy is likely to bring significant commercial returns. Mergers and acquisitions (M&A) facilitate market... 2012-03-27

BMI View: Argentina's pharmaceutical market is a very attractive proposition in Latin America because of the large, ageing population and relatively wide-ranging medicine reimbursement... 2012-03-26

BMI Core View: Some multinational pharmaceutical companies will partner with generic drugmakers based in emerging markets to increase sales of their innovative medicines. By leveraging... 2012-03-20

BMI View: Multinational drugmakers will benefit from Argentina's plans to implement a traceability system for pharmaceutical products as they will have chance to take back the market... 2012-02-16

BMI View: Government interference and spiralling inflation in Argentina create a less investor-friendly environment for multinational pharmaceutical companies. However, it will be viewed... 2012-02-14

BMI View: Argentina's retail pharmacy sector should provide a very rewarding market for multinational companies. However, government policy and legislation is heavily biased towards... 2012-01-27

BMI View: The increase in medicine freight service between Brazil, Argentina and the UAE will strengthen the ties between these countries and benefit pharmaceutical companies, which... 2012-01-19

BMI Core View: Corporate social responsibility (CSR) is an underappreciated business activity in the pharmaceutical industry. Like all commercial entities, drugmakers are fully entitled... 2012-01-05

BMI View: The new Argentine pharmaceutical depot, to be constructed by Marken, will benefit local and international pharmaceutical companies. BMI believes Argentina is attractive to... 2011-12-23

BMI View: Despite having a highly capable domestic research sector and Latin America's first clinical trials registry, Argentina has seen a decline in the number of drugmakers and clinical... 2011-11-30